Hosted on MSN39m
Shionogi’s RSV antiviral reduces viral load in Phase II human challenge trial
Shionogi’s oral antiviral for respiratory syncytial virus (RSV) has met its primary endpoint in a Phase II study that saw some participants achieving an 88.94% reduction in viral load. The Japanese ...
Collision between helicopter and jetliner kills 67 in nation’s worst air disaster in a generation
A midair collision between an Army helicopter and an American Airlines flight from Kansas killed all 67 people aboard the two aircraft ...